News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,983 Results
Type
Article (16456)
Company Profile (110)
Press Release (280408)
Multimedia
Podcasts (68)
Webinars (14)
Section
Business (93085)
Career Advice (769)
Deals (16125)
Drug Delivery (80)
Drug Development (39269)
Employer Resources (78)
FDA (7007)
Job Trends (6765)
News (159924)
Policy (15540)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (720)
Accelerated approval (14)
Adcomms (11)
Allergies (70)
Alliances (24951)
ALS (67)
Alzheimer's disease (583)
Antibody-drug conjugate (ADC) (104)
Approvals (7198)
Artificial intelligence (227)
Autoimmune disease (47)
Automation (15)
Bankruptcy (157)
Best Places to Work (4847)
BIOSECURE Act (10)
Biosimilars (126)
Biotechnology (42)
Bladder cancer (49)
Brain cancer (35)
Breast cancer (202)
Cancer (1556)
Cardiovascular disease (162)
Career advice (665)
Career pathing (17)
CAR-T (53)
CDC (8)
Cell therapy (186)
Cervical cancer (14)
Clinical research (33996)
Collaboration (802)
Compensation (329)
Complete response letters (34)
COVID-19 (980)
CRISPR (50)
C-suite (447)
Cystic fibrosis (67)
Data (2132)
Denatured (20)
Depression (56)
Diabetes (143)
Diagnostics (1768)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (17)
Drug discovery (122)
Drug pricing (124)
Drug shortages (13)
Duchenne muscular dystrophy (97)
Earnings (35026)
Editorial (26)
Employer branding (7)
Employer resources (67)
Events (41757)
Executive appointments (547)
FDA (8257)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (1)
Funding (522)
Gene editing (84)
Generative AI (23)
Gene therapy (215)
GLP-1 (468)
Government (1867)
Grass and pollen (4)
Guidances (174)
Healthcare (4694)
HIV (24)
Huntington's disease (14)
IgA nephropathy (42)
Immunology and inflammation (77)
Immuno-oncology (15)
Indications (58)
Infectious disease (1060)
Inflammatory bowel disease (81)
Inflation Reduction Act (7)
Influenza (32)
Intellectual property (124)
Interviews (128)
IPO (6282)
IRA (37)
Job creations (2140)
Job search strategy (571)
JPM (30)
Kidney cancer (9)
Labor market (28)
Layoffs (230)
Leadership (13)
Legal (3642)
Liver cancer (24)
Longevity (8)
Lung cancer (214)
Lymphoma (138)
Machine learning (14)
Management (29)
Manufacturing (454)
MASH (70)
Medical device (2046)
Medtech (2056)
Mergers & acquisitions (10298)
Metabolic disorders (470)
Multiple sclerosis (49)
NASH (14)
Neurodegenerative disease (101)
Neuropsychiatric disorders (42)
Neuroscience (1069)
Neurotech (1)
NextGen: Class of 2026 (1869)
Non-profit (1019)
Now hiring (17)
Obesity (244)
Opinion (183)
Ovarian cancer (44)
Pain (112)
Pancreatic cancer (56)
Parkinson's disease (105)
Partnered (15)
Patents (241)
Patient recruitment (141)
Peanut (14)
People (31045)
Pharmaceutical (64)
Pharmacy benefit managers (22)
Phase 1 (9036)
Phase 2 (14502)
Phase 3 (12741)
Pipeline (2129)
Policy (148)
Postmarket research (1436)
Preclinical (3714)
Press Release (30)
Prostate cancer (101)
Psychedelics (22)
Radiopharmaceuticals (142)
Rare diseases (401)
Real estate (2821)
Recruiting (32)
Regulatory (11916)
Reports (18)
Research institute (815)
Resumes & cover letters (108)
Rett syndrome (12)
RNA editing (7)
RSV (22)
Schizophrenia (75)
Series A (90)
Series B (52)
Service/supplier (3)
Sickle cell disease (52)
Special edition (11)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (1765)
State (2)
Stomach cancer (6)
Supply chain (52)
Tariffs (71)
The Weekly (46)
Vaccines (285)
Venture capital (37)
Weight loss (149)
Women's health (33)
Worklife (6)
Date
Today (6)
Last 7 days (204)
Last 30 days (848)
Last 365 days (11606)
2026 (1072)
2025 (11894)
2024 (13761)
2023 (15555)
2022 (21572)
2021 (22287)
2020 (21913)
2019 (16956)
2018 (13386)
2017 (14929)
2016 (14152)
2015 (16582)
2014 (13270)
2013 (11230)
2012 (12010)
2011 (12527)
2010 (11342)
Location
Africa (378)
Alabama (19)
Alaska (2)
Arizona (88)
Arkansas (4)
Asia (22262)
Australia (2922)
California (3558)
Canada (1624)
China (586)
Colorado (152)
Connecticut (142)
Delaware (144)
Europe (43945)
Florida (669)
Georgia (88)
Hawaii (2)
Idaho (15)
Illinois (385)
India (48)
Indiana (243)
Iowa (4)
Japan (254)
Kansas (80)
Kentucky (21)
Louisiana (5)
Maine (7)
Maryland (478)
Massachusetts (2844)
Michigan (62)
Minnesota (207)
Mississippi (1)
Missouri (43)
Montana (9)
Nebraska (8)
Nevada (20)
New Hampshire (27)
New Jersey (1534)
New Mexico (7)
New York (994)
North Carolina (670)
North Dakota (2)
Northern California (1606)
Ohio (94)
Oklahoma (6)
Oregon (19)
Pennsylvania (768)
Puerto Rico (12)
Rhode Island (19)
South America (561)
South Carolina (13)
Southern California (1570)
Tennessee (63)
Texas (523)
United States (14104)
Utah (76)
Virginia (167)
Washington D.C. (45)
Washington State (257)
West Virginia (2)
Wisconsin (41)
Wyoming (1)
296,983 Results for "essential pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
WHO Adds GLP-1s to List of Essential Medicines
The World Health Organization’s Essential Medicines list guides high-level procurement and coverage decisions for over 150 countries.
September 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
December 29, 2025
·
5 min read
Press Releases
FDA Confirms a PDUFA Goal Date of August 30, 2026 for the sBLA Submission of Ropeginterferon Alfa-2b-njft in Essential Thrombocythemia (ET)
January 13, 2026
·
6 min read
Press Releases
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
December 5, 2025
·
5 min read
Press Releases
Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor
October 17, 2025
·
12 min read
Press Releases
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
July 3, 2025
·
2 min read
Press Releases
PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
January 12, 2026
·
9 min read
Obesity
WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List:
Reuters
In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, which the agency decided against listing in 2023, the last time the Essential Medicines list was updated.
May 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Genesee Scientific Acquires Jade Scientific, Expanding Capabilities in Lab Essentials Market
September 16, 2025
·
2 min read
Press Releases
CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson’s Disease in Patients with Essential Tremor
October 23, 2025
·
6 min read
1 of 29,699
Next
